Cormorant Asset Management, LP Orchard Therapeutics PLC Transaction History

Cormorant Asset Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$5.65 - $15.71 $528,580 - $1.47 Million	-93,554 Reduced 26.71%	256,649 $1.93 Million
Q4 2019 Feb 14, 2020	SELL	$10.15 - $15.58 $3.3 Million - $5.07 Million	-325,122 Reduced 48.14%	350,203 $4.82 Million
Q3 2019 Nov 14, 2019	SELL	$11.88 - $16.72 $653,400 - $919,599	-55,000 Reduced 7.53%	675,325 $8.02 Million
Q2 2019 Aug 14, 2019	BUY	$13.2 - $20.63 $1.06 Million - $1.65 Million	80,182 Added 12.33%	730,325 $10.2 Million
Q1 2019 May 15, 2019	BUY	$12.01 - $19.49 $3.3 Million - $5.36 Million	275,143 Added 73.37%	650,143 $11.6 Million
Q4 2018 Feb 14, 2019	BUY	$12.4 - $18.7 $4.65 Million - $7.01 Million	375,000 New	375,000 $5.9 Million

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cormorant Asset Management, LP with notifications on news.